Description
DRUGS FOR DIRECT PATIENT CARE
First action · last action
2019-04-04 · 2020-07-21
Transactions
4
First transaction's obligation
$921,220
Base + all options value (sum of deltas)
$920,784
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D50358
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-04-04+$921,220= $921,220
- Mod P000012019-09-30+$13,932= $935,152
- Mod P000032020-04-29-$14,336= $920,816
- Mod P000042020-07-21-$32= $920,784
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-04-04 | +$921,220 | $921,220 | DRUGS FOR DIRECT PATIENT CARE |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-09-30 | +$13,932 | $935,152 | DRUGS FOR DIRECT PATIENT CARE |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-04-29 | −$14,336 | $920,816 | DRUGS FOR DIRECT PATIENT CARE |
| Mod P00004· FUNDING ONLY ACTION | 2020-07-21 | −$32 | $920,784 | DRUGS FOR DIRECT PATIENT CARE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI H3WKVE9VBLY3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826F0207 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $183,903 | FY2026 |
| 36C24826F0187 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $36,781 | FY2026 |
| 36C25226F0318 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $85,484 | FY2026 |
| 36C24826F0091 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $147,122 | FY2026 |
| 36C24826F0037 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $124,240 | FY2026 |
| 36C24824F0327 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $391,583 | FY2024 |
Other recipients under 6505 from 258-NETWORK CNTRCT OFF 22G (36C258) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25821P0342 | MCKESSON CORPORATION | 258-NETWORK CNTRCT OFF 22G (36C258) | $750 | FY2021 |
| 36C25821N0393 | UNIVERSITY OF NEW MEXICO | 258-NETWORK CNTRCT OFF 22G (36C258) | $31,866 | FY2021 |
| 36C25821P0312 | LANTHEUS MEDICAL IMAGING, INC. | 258-NETWORK CNTRCT OFF 22G (36C258) | $101,384 | FY2021 |
| 36C25821N0375 | CARDINAL HEALTH 414, LLC | 258-NETWORK CNTRCT OFF 22G (36C258) | $182,654 | FY2021 |
| 36C25821N0374 | CHIESI USA INC | 258-NETWORK CNTRCT OFF 22G (36C258) | $75,951 | FY2021 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25819N0230_3600_V797D50358_3600 · retrieved 2026-09-26.